|
Market Closed -
NSE India S.E.
04:35:07 20/05/2026 pm IST
|
5-day change
|
1st Jan Change
|
|
6,893.00 INR
|
-0.27%
|
 |
+3.75%
|
+7.83%
|
|
01/04 |
Avendus Spark Upgrades Divi's Laboratories to Reduce from Sell, Price Target is INR5,840
|
MT
| |
12/02 |
Jefferies Adjusts Divi's Laboratories' Price Target to INR8,100 From INR8,000, Keeps at Buy
|
MT
| |
11/02 |
Divi's Laboratories Limited, Q3 2026 Earnings Call, Feb 11, 2026
| | |
11/02 |
Divi's Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
|
CI
| |
11/02 |
Indian contract drug maker Divi's misses profit view on high material costs, one-off labour charge
|
RE
| |
11/02 |
Divi's Laboratories Q3 consol net profit 5.83 billion rupees
|
RE
| |
14/11 |
Divi's Labs Unit-I inspection by US FDA concluded
|
RE
| |
10/11 |
Jefferies Adjusts Divi's Laboratories' Price Target to INR7,850 From INR7,150, Keeps at Buy
|
MT
| |
07/11 |
Divi's Laboratories Limited, Q2 2026 Earnings Call, Nov 07, 2025
| | |
07/11 |
Divi's Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
|
CI
| |
07/11 |
Divi's Laboratories' Consolidated Profit Grows in Fiscal Q2
|
MT
| |
07/11 |
Indian drugmaker Divi's beats profit view for second quarter on API boost
|
RE
| |
07/11 |
Divi's Labs Sept-quarter consol net profit 6.89 billion rupees
|
RE
| |
07/11 |
Divi's Laboratories Limited Approves Change in Designation of Nimmagadda Venkata Anirudh as President and Senior Management Personnel, Effective November 07, 2025
|
CI
| |
05/25/05 |
Divi's Laboratories Limited Announces Cessation of Y.S. Koteswara Rao, as Senior Management Personnel, Effective September 05, 2025
|
CI
| |
07/25/07 |
Jefferies Adjusts Divi's Laboratories' Price Target to INR6,750 From INR6,200, Keeps at Hold
|
MT
| |
06/25/06 |
Divi's Laboratories Limited, Q1 2026 Earnings Call, Aug 06, 2025
| | |
06/25/06 |
Divi's Laboratories' Consolidated Profit Grows in Fiscal Q1; Shares Down Over 3%
|
MT
| |
06/25/06 |
Divi's Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
|
CI
| |
06/25/06 |
Indian drugmaker Divi's misses June-quarter profit view on weak US pricing
|
RE
| |
25/25/25 |
For final dividend
|
FA
| |
14/25/14 |
Divi Laboratories : 35th Annual Report 2024-25
|
PU
| |
14/25/14 |
Divi Laboratories : 35th Annual Report 2024-25 Subsidiary Financials
|
PU
| |
14/25/14 |
Divi Laboratories : 35th Annual Report 2024-25 AGM Notice
|
PU
| |
20/25/20 |
Divi's Laboratories Limited announces Annual dividend, payable on September 10, 2025
|
CI
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
